Frontlight ResearchEarly access
Not yet recruitingPhase 2
Mesotherapy as a treatment for irritable bowel syndrome
Tests mesotherapy, small skin injections, in adults with irritable bowel syndrome.
Key facts
- Who runs it
- Polyclinique De L'europe
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Mesotherapy treatment of irritable bowel syndrome
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 27 people, planned
- Started
- 15 Jan 2024
- Planned end
- 15 Jan 2026
- Type of study
- Interventional
- Record updated
- 8 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with irritable bowel syndrome, to test mesotherapy as a treatment.
- Age
- 18 Years and older
- Sex
- All sexes can join
Main reasons for not taking part
- Healthy volunteers cannot join
Where is this trial?
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Mesotherapy as a treatment for irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 8 February 2024